JP2024500512A5 - - Google Patents

Info

Publication number
JP2024500512A5
JP2024500512A5 JP2023539061A JP2023539061A JP2024500512A5 JP 2024500512 A5 JP2024500512 A5 JP 2024500512A5 JP 2023539061 A JP2023539061 A JP 2023539061A JP 2023539061 A JP2023539061 A JP 2023539061A JP 2024500512 A5 JP2024500512 A5 JP 2024500512A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
sequence shown
seq
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023539061A
Other languages
English (en)
Japanese (ja)
Other versions
JP7871265B2 (ja
JP2024500512A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/140449 external-priority patent/WO2022135467A1/zh
Publication of JP2024500512A publication Critical patent/JP2024500512A/ja
Publication of JP2024500512A5 publication Critical patent/JP2024500512A5/ja
Application granted granted Critical
Publication of JP7871265B2 publication Critical patent/JP7871265B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023539061A 2020-12-23 2021-12-22 抗b7-h3抗体およびその使用 Active JP7871265B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202011544445 2020-12-23
CN202011544445.8 2020-12-23
PCT/CN2021/140449 WO2022135467A1 (zh) 2020-12-23 2021-12-22 抗b7-h3抗体及其用途

Publications (3)

Publication Number Publication Date
JP2024500512A JP2024500512A (ja) 2024-01-09
JP2024500512A5 true JP2024500512A5 (cg-RX-API-DMAC7.html) 2025-01-07
JP7871265B2 JP7871265B2 (ja) 2026-06-08

Family

ID=82157408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023539061A Active JP7871265B2 (ja) 2020-12-23 2021-12-22 抗b7-h3抗体およびその使用

Country Status (8)

Country Link
US (1) US20240043540A1 (cg-RX-API-DMAC7.html)
EP (1) EP4269435A4 (cg-RX-API-DMAC7.html)
JP (1) JP7871265B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230124959A (cg-RX-API-DMAC7.html)
CN (1) CN117098548A (cg-RX-API-DMAC7.html)
AU (1) AU2021407023B2 (cg-RX-API-DMAC7.html)
CA (1) CA3203257A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022135467A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119948063A (zh) * 2022-06-23 2025-05-06 信达生物制药(苏州)有限公司 结合egfr和b7-h3的双特异性抗体
WO2024007129A1 (zh) * 2022-07-04 2024-01-11 英诺湖医药(杭州)有限公司 人源化的b7h3抗体或其抗原结合片段
CN119925631A (zh) * 2023-11-03 2025-05-06 信达生物制药(苏州)有限公司 靶向b7-h3的抗体-药物偶联物及其用途
WO2025131054A1 (en) * 2023-12-22 2025-06-26 Innovent Biologics (Suzhou) Co., Ltd. Antibody drug conjugates targeting to b7-h3 and egfr and the use thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・2・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
EP0604580A1 (en) 1991-09-19 1994-07-06 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES
AU691811B2 (en) 1993-06-16 1998-05-28 Celltech Therapeutics Limited Antibodies
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
CA2323757C (en) 1998-04-02 2011-08-02 Genentech, Inc. Antibody variants and fragments thereof
US6194551B1 (en) 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
HUP0104865A3 (en) 1999-01-15 2004-07-28 Genentech Inc Polypeptide variants with altered effector function
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
HUE035898T2 (en) 2002-12-16 2018-05-28 Genentech Inc Immunoglobulin variants and their applications
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
US8242247B2 (en) 2007-12-21 2012-08-14 Hoffmann-La Roche Inc. Bivalent, bispecific antibodies
US8227577B2 (en) 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
US20090162359A1 (en) 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
BRPI1014089A2 (pt) 2009-04-02 2016-04-19 Roche Glycart Ag anticorpos multiespecíficos que compreendem anticorpos de comprimento completo e fragmentos fab de cadeia simples
PT2417156E (pt) 2009-04-07 2015-04-29 Roche Glycart Ag Anticorpos trivalentes, biespecíficos
SG176219A1 (en) 2009-05-27 2011-12-29 Hoffmann La Roche Tri- or tetraspecific antibodies
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
US8703132B2 (en) 2009-06-18 2014-04-22 Hoffmann-La Roche, Inc. Bispecific, tetravalent antigen binding proteins
DK2542256T3 (da) * 2010-03-04 2019-08-26 Macrogenics Inc Antistoffer reagerende med b7-h3, immunologisk aktive fragmenter deraf og anvendelser deraf
PH12012501751A1 (en) * 2010-03-04 2012-11-12 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
EP2703486B1 (en) * 2011-04-25 2018-03-07 Daiichi Sankyo Company, Limited Anti-b7-h3 antibody
KR102485788B1 (ko) 2014-08-27 2023-01-09 메모리얼 슬로안 케터링 캔서 센터 항체, 조성물 및 용도
US10865245B2 (en) * 2014-12-23 2020-12-15 Full Spectrum Genetics, Inc. Anti-B7H3 binding compounds and uses thereof
RS61828B1 (sr) * 2016-06-08 2021-06-30 Abbvie Inc Anti-b7-h3 antitela i antitelske konjugacije lekova
CN109843927B (zh) * 2017-03-06 2022-06-21 江苏恒瑞医药股份有限公司 抗b7-h3抗体、其抗原结合片段及其医药用途
TW201909926A (zh) * 2017-08-04 2019-03-16 大陸商江蘇恆瑞醫藥股份有限公司 B7h3抗體-藥物偶聯物及其醫藥用途
WO2020094120A1 (zh) * 2018-11-09 2020-05-14 上海复旦张江生物医药股份有限公司 一种抗b7-h3抗体及其制备方法、其偶联物和应用
CN109851673B (zh) * 2019-01-22 2023-07-25 苏州旭光科星抗体生物科技有限公司 一种抗人b7-h3单克隆抗体的制备方法及其免疫组化检测方法及其应用及其试剂盒
CN111944050B (zh) * 2020-08-19 2022-05-13 苏州普乐康医药科技有限公司 一种抗b7-h3抗体及其应用

Similar Documents

Publication Publication Date Title
JP7412521B2 (ja) Cd47に対するヒト化及びキメラモノクローナル抗体
CN110536903A (zh) 抗ox40抗体及其用途
CN112135626A (zh) 抗tigit抗体及其用途
JP2022533538A5 (cg-RX-API-DMAC7.html)
RU2015142815A (ru) Лечение рака с использованием антител, связывающихся с поверхностным grp78
JP2020522280A5 (cg-RX-API-DMAC7.html)
EP2928919A2 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins
CN112513094A (zh) 结合人her2的抗体、其制备方法和用途
JP2020522281A5 (cg-RX-API-DMAC7.html)
EP3092252B1 (en) Antibody targeting cell surface deposited complement protein c3d and use thereof
JP2024540148A5 (cg-RX-API-DMAC7.html)
KR20220167331A (ko) 항-flt3 항체 및 조성물
CN117500833A (zh) 一种双抗组合及其应用
WO2021098822A1 (zh) 一种双特异性抗体
KR20250152073A (ko) 항체, 항원 결합 단편 및 사용 방법
CN109414489B (zh) 网蛋白-1结合抗体及其用途
CN116249547B (zh) 脑特异性血管生成抑制剂1(bai1)抗体及其用途
CN112805297B (zh) 抗人类pd-l1抗体及其用途
CN112969715A (zh) 一种抗cd47抗原结合蛋白及其应用
JP2024516621A5 (cg-RX-API-DMAC7.html)
CN111246881A (zh) Pd-1抗体用于治疗肿瘤的用途
JP7808831B2 (ja) 抗cd26抗体とその応用
JP2024536358A5 (cg-RX-API-DMAC7.html)
WO2024131846A1 (en) Antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
WO2025146161A1 (en) Antibody, antigen-binding fragment and medical use thereof